1. Home
  2. FNB vs LQDA Comparison

FNB vs LQDA Comparison

Compare FNB & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo F.N.B. Corporation

FNB

F.N.B. Corporation

HOLD

Current Price

$17.73

Market Cap

6.8B

Sector

Finance

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$67.41

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNB
LQDA
Founded
1864
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
5.5B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
FNB
LQDA
Price
$17.73
$67.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
11
Target Price
$19.70
$41.00
AVG Volume (30 Days)
3.2M
965.1K
Earning Date
04-16-2026
05-08-2026
Dividend Yield
2.97%
N/A
EPS Growth
22.83
51.81
EPS
0.80
1.26
Revenue
N/A
$158,320,000.00
Revenue This Year
$14.12
$278.87
Revenue Next Year
$8.35
$57.13
P/E Ratio
$22.39
$52.72
Revenue Growth
N/A
1031.18
52 Week Low
$14.46
$21.15
52 Week High
$19.59
$93.61

Technical Indicators

Market Signals
Indicator
FNB
LQDA
Relative Strength Index (RSI) 38.00 40.74
Support Level $17.87 $62.86
Resistance Level $18.28 $92.35
Average True Range (ATR) 0.30 2.48
MACD -0.03 0.32
Stochastic Oscillator 30.21 46.67

Price Performance

Historical Comparison
FNB
LQDA

About FNB F.N.B. Corporation

F N B Corp provides a full range of financial services, principally to consumers, corporations, governments, and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management, and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: